Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesTranscriptional analysis of doxorubicin-induced cytotoxicity and resistance in human hepatocellular carcinoma cell lines
Liver International, 09/10/09
Wang J et al. – The results reveal novel co–ordinated changes that occurred in resistant HepG2 cells to survive from cell apoptosis elicited by Dox treatment.
Related Articles
MiR-122 affects the viability and apoptosis of hepatocellular carcinoma cells
Scandinavian Journal of Gastroenterology, 11/06/09
Relevance Score: 81%
Cryotherapy for hepatocellular carcinoma
Cochrane Reviews, 10/09/09
Relevance Score: 81%
Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells
Hepatology, 11/11/09
Relevance Score: 80%
Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH
Journal of Cancer Research & Clinical Oncology, 10/23/09
Relevance Score: 80%
Kupffer Cell Suppression of CD8+ T Cells in Human Hepatocellular Carcinoma Is Mediated by B7-H1/Programmed Death-1 Interactions
Cancer Research, 10/21/09
Relevance Score: 80%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Invasive front of colorectal cancer: Dynamic interface of pro-/anti-tumor factors
World Journal of Gastroenterology, 12/17/09
Molecular chemoprevention of colorectal malignancy by mesalazine
Alimentary Pharmacology and Therapeutics, 12/17/09
Multidrug resistance protein 3 R652G may reduce susceptibility to idiopathic infant cholestasis
World Journal of Gastroenterology, 12/17/09
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Delay in Diagnostic Workup and Treatment of Esophageal Cancer
Journal of Gastrointestinal Surgery, 12/17/09
Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours
Alimentary Pharmacology and Therapeutics, 12/17/09
Today in Hepatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Influenza Vaccination in Liver Transplant Recipients
Transplantation, 12/17/09
Screening for hepatitis B in chemotherapy patients: survey of current oncology practices
Alimentary Pharmacology and Therapeutics, 12/17/09
Spontaneous liver rupture in hypereosinophilic syndrome: A rare but fatal complication
World Journal of Gastroenterology, 12/17/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Pilot study: the use of sulfasalazine for the treatment of acute pouchitis
Alimentary Pharmacology and Therapeutics, 12/17/09
Clinical outcome of newly diagnosed Crohns disease: a comparative, retrospective study before and after infliximab availability
Alimentary Pharmacology and Therapeutics, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor